Sisram Medical Ltd (HKG:1696)

Sisram Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	345.86	349.11	359.29	354.48	294.29	162.1
Revenue Growth (YoY)	-2.96%	-2.83%	1.36%	20.45%	81.56%	-6.58%
Cost of Revenue	135.14	132.43	139.77	152.25	127.43	71.79
Gross Profit	210.72	216.68	219.53	202.23	166.86	90.3
Selling, General & Admin	165.8	165.09	159.44	128.76	100.71	58.96
Research & Development	15.92	15.94	18.03	18.02	15.59	10.96
Other Operating Expenses	7.12	7.98	4.03	10.04	7.8	3.78
Operating Expenses	188.84	189	181.5	156.82	124.1	73.7
Operating Income	21.88	27.68	38.03	45.41	42.76	16.6
Interest Expense	-2.71	-2.46	-2.06	-1.74	-2.01	-1.06
Interest & Investment Income	0.61	0.79	0.6	0.61	0.54	0.77
Earnings From Equity Investments	-0.09	0.03	-0.42	-0.52	-0.31	-
Currency Exchange Gain (Loss)	3.57	-	-	-	0.49	-
Other Non Operating Income (Expenses)	2.19	2.35	0.99	0.48	0.19	0.01
EBT Excluding Unusual Items	25.46	28.39	37.13	44.24	41.67	16.32
Gain (Loss) on Sale of Investments	4.15	4.15	-	-	-	-
Other Unusual Items	-	-	-	-	-	0.34
Pretax Income	29.61	32.54	37.13	44.24	41.67	16.66
Income Tax Expense	5.06	3.78	4.23	4.16	9.15	1.98
Earnings From Continuing Operations	24.55	28.77	32.9	40.08	32.52	14.68
Minority Interest in Earnings	-3.95	-3.64	-1.4	0.09	-1.28	-1.34
Net Income	20.6	25.13	31.5	40.17	31.25	13.34
Net Income to Common	20.6	25.13	31.5	40.17	31.25	13.34
Net Income Growth	-12.53%	-20.23%	-21.59%	28.57%	134.15%	-35.80%
Shares Outstanding (Basic)	468	468	467	466	453	442
Shares Outstanding (Diluted)	468	468	468	467	453	442
Shares Change (YoY)	0.09%	-	0.34%	3.07%	2.42%	-
EPS (Basic)	0.04	0.05	0.07	0.09	0.07	0.03
EPS (Diluted)	0.04	0.05	0.07	0.09	0.07	0.03
EPS Growth	-12.79%	-20.36%	-21.84%	24.78%	128.63%	-35.80%
Free Cash Flow	20.82	30.33	35.37	17.29	29.41	16.46
Free Cash Flow Per Share	0.04	0.07	0.08	0.04	0.07	0.04
Dividend Per Share	0.016	0.016	0.020	0.022	0.020	0.009
Dividend Growth	-19.80%	-19.80%	-8.84%	10.20%	123.02%	-36.07%
Gross Margin	60.93%	62.07%	61.10%	57.05%	56.70%	55.71%
Operating Margin	6.33%	7.93%	10.58%	12.81%	14.53%	10.24%
Profit Margin	5.96%	7.20%	8.77%	11.33%	10.62%	8.23%
Free Cash Flow Margin	6.02%	8.69%	9.84%	4.88%	9.99%	10.16%
EBITDA	33.03	38.91	47.5	53.99	51.58	23.8
EBITDA Margin	9.55%	11.14%	13.22%	15.23%	17.53%	14.68%
D&A For EBITDA	11.16	11.23	9.47	8.59	8.82	7.2
EBIT	21.88	27.68	38.03	45.41	42.76	16.6
EBIT Margin	6.33%	7.93%	10.58%	12.81%	14.53%	10.24%
Effective Tax Rate	17.08%	11.60%	11.40%	9.41%	21.96%	11.89%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.